TMC435 HPC1004 - Phase I Study Investigating the Pharmacokinetics of TMC435 in Healthy Chinese Volunteers
Clinical trial NCT01224197 · COMPLETED
Trial details
- NCT number
- NCT01224197
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-01-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.